Publications by authors named "Peter A Revill"

Claim this Profile
A
Availability of point-of-care HBV tests in resource-limited settings.
Daryl T Y Lau, Kathy Jackson, Camila A Picchio, Anna Kramvis, Mark Sonderup, Peter A Revill

Lancet Gastroenterol Hepatol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CRISPR-Cas13b-mediated suppression of HBV replication and protein expression.
Laura C McCoullough, Mohamed Fareh, Wenxin Hu, Vitina Sozzi, Christina Makhlouf, Peter A Revill

J Hepatol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High end-of-treatment hepatitis B core-related antigen levels predict hepatitis flare after stopping nucleot(s)ide analogue therapy.
Simon J Hume, Danny K Wong, Man-Fung Yuen, Kathy Jackson, Sara Bonanzinga, Peter A Revill

Liver Int· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Highlights from the 2023 International Meeting on the Molecular Biology of Hepatitis B virus.

J Gen Virol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The replication phenotype of hepatitis B virus (HBV) splice variants Sp3 and Sp9 and their impact on wild-type HBV replication.
Laura C McCoullough, Tomas Sadauskas, Vitina Sozzi, Kai Yan Mak, Hugh Mason, Peter A Revill

J Virol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline serum HBV RNA is associated with the risk of hepatitis flare after stopping nucleoside analog therapy in HBeAg-negative participants.
Alexander J Thompson, Kathy Jackson, Sara Bonanzinga, Sam A L Hall, Simon Hume, Peter A Revill

Hepatol Commun· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis B virus haplotype number at baseline is a predictive marker of functional cure during antiviral therapy for patients with genotypes A and D HBeAg-positive chronic hepatitis B.
Josef Wagner, Lilly Yuen, Margaret Littlejohn, Vitina Sozzi, Kathy Jackson, Peter A Revill

Aliment Pharmacol Ther· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: baseline hepatitis B virus haplotype number may help predict a functional cure in patients with chronic hepatitis B treated with nucleotide analogues-authors' reply.
Josef Wagner, Margaret Littlejohn, Peter A Revill

Aliment Pharmacol Ther· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HIV DNA persists in hepatocytes in people with HIV-hepatitis B co-infection on antiretroviral therapy.
Jennifer M Zerbato, Anchalee Avihingsanon, Kasha P Singh, Wei Zhao, Claire Deleage, Peter A Revill

EBioMedicine· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis B Virus Flares After Nucleot(s)ide Analogue Cessation Are Associated With Activation of Toll-Like Receptor Signaling Pathways.
Samuel A L Hall, Gareth S Burns, Benjamin J Mooney, Rosemary Millen, Rachel Morris, Peter A Revill

J Infect Dis· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A roadmap for serum biomarkers for hepatitis B virus: current status and future outlook.
Anna Kramvis, Kyong-Mi Chang, Maura Dandri, Patrizia Farci, Dieter Glebe, Peter A Revill

Nat Rev Gastroenterol Hepatol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the Public Health and Social Implications of Future Curative Hepatitis B Interventions.
Jack Wallace, Jacqueline Richmond, Jessica Howell, Behzad Hajarizadeh, Jennifer Power, Peter A Revill

Viruses· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secreted hepatitis B virus splice variants differ by HBV genotype and across phases of chronic hepatitis B infection.
Olivia Maslac, Josef Wagner, Vitina Sozzi, Hugh Mason, Jenny Svarovskaia, Peter A Revill

J Viral Hepat· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stopping nucleot(s)ide analogues in non-cirrhotic HBeAg-negative chronic hepatitis B patients: HBsAg loss at 96 weeks is associated with low baseline HBsAg levels.
Samuel A L Hall, Gareth S Burns, Despina Anagnostou, Sara Vogrin, Vijaya Sundararajan, Peter A Revill

Aliment Pharmacol Ther· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The price tag of a potential cure for chronic hepatitis B infection: A cost threshold analysis for USA, China and Australia.
Mehlika Toy, David Hutton, Karen McCulloch, Nicole Romero, Peter A Revill

Liver Int· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of anti-HBs in functional cure of HBeAg+ chronic hepatitis B patients infected with HBV genotype A.
Hui Xu, Stephen Locarnini, Darren Wong, Rachel Hammond, Danni Colledge, Peter A Revill

J Hepatol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gut microbiomes from Gambian infants reveal the development of a non-industrialized Prevotella-based trophic network.
Marcus C de Goffau, Amadou T Jallow, Chilel Sanyang, Andrew M Prentice, Niamh Meagher, Peter A Revill

Nat Microbiol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infection courses, virological features and IFN-α responses of HBV genotypes in cell culture and animal models.
Min Zhang, Zhensheng Zhang, Michio Imamura, Mitsutaka Osawa, Yuji Teraoka, Peter A Revill

J Hepatol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization and Application of Precore/Core-Related Antigens in Animal Models of Hepatitis B Virus Infection.
Xupeng Hong, Laurie Luckenbaugh, David Perlman, Peter A Revill, Stefan F Wieland

Hepatology· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of Hepatitis B Virus Haplotype Diversity Detects Striking Sequence Conservation Across Genotypes and Chronic Disease Phase.
Josef Wagner, Lilly Yuen, Margaret Littlejohn, Vitina Sozzi, Kathy Jackson, Peter A Revill

Hepatology· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Viperin binds STING and enhances the type-I interferon response following dsDNA detection.
Keaton M Crosse, Ebony A Monson, Arti B Dumbrepatil, Monique Smith, Yeu-Yang Tseng, Peter A Revill

Immunol Cell Biol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of Hepatitis B Precore/Core-Related Antigens.
Xupeng Hong, Laurie Luckenbaugh, Megan Mendenhall, Renae Walsh, Liza Cabuang, Peter A Revill

J Virol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative analysis of the splice variants expressed by the major hepatitis B virus genotypes.
Chun Shen Lim, Vitina Sozzi, Margaret Littlejohn, Lilly K W Yuen, Nadia Warner, Peter A Revill

Microb Genom· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The evolution and clinical impact of hepatitis B virus genome diversity.
Peter A Revill, Thomas Tu, Hans J Netter, Lilly K W Yuen, Stephen A Locarnini

Nat Rev Gastroenterol Hepatol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intrahepatic CXCL10 is strongly associated with liver fibrosis in HIV-Hepatitis B co-infection.
Kasha P Singh, Jennifer M Zerbato, Wei Zhao, Sabine Braat, Claire Deleage, Peter A Revill

PLoS Pathog· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis